Filing Details
- Accession Number:
- 0001144204-18-012533
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-02 16:07:02
- Reporting Period:
- 2018-02-28
- Accepted Time:
- 2018-03-02 16:07:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533998 | Dariohealth Corp. | DRIO | Surgical & Medical Instruments & Apparatus (3841) | 452973162 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1667943 | Zvi Ben-David | 8 Hatokhen Street Caesarea Industrial Park L3 3088900 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-02-28 | 9,018 | $1.40 | 9,018 | No | 4 | P | Indirect | By spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By spouse |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series C Convertible Preferred Stock | Acquisiton | 2018-02-28 | 13,349 | $2.80 | 26,698 | $1.40 |
Common Stock | Warrant to purchase Common Stock | Acquisiton | 2018-02-28 | 28,573 | $0.00 | 28,573 | $1.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,349 | No | 4 | P | Indirect | ||
28,573 | 2018-08-28 | 2019-08-28 | No | 4 | P | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 435,766 | Direct |
Footnotes
- The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- The Series C Convertible Preferred Stock automatically converts into Common Stock on a 1:2 basis upon shareholder approval of the conversion and has no expiration date.
- The Warrants were issued in connection with the purchase of the Common Stock and the Series C Convertible Preferred Stock reported herein.